Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Cyclooxygenase-2-inhibitors described by Japan Tobacco

Aug. 23, 1996

Cyclooxygenase-2 inhibitors from Merck Frosst

Aug. 23, 1996

Protease inhibitors from Sankyo

Aug. 23, 1996

SmithKline Beecham describes protease inhibitors

Aug. 23, 1996

Takeda describes cephem antibacterial agents

Aug. 23, 1996

More tachykinin NK1 antagonists reported by Sandoz

Aug. 23, 1996

Coagulation factor X inhibitors described by Yamanouchi

Aug. 16, 1996

Beta3 agonists reported by Dainippon

Aug. 16, 1996

Sanofi describes fibrinogen antagonists

Aug. 16, 1996

Fibrinogen antagonists claimed by Toyama

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...